Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1513/AnnalsATS.201605-330LE | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Editorial Comment on "Indwelling Urological Device Biofilm Composition and Characteristics in the Presence and Absence of Infection".
Urology
November 2024
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH.
In Reply to the Letter to the Editor Regarding: Preventing Ventricular Catheter Displacement and Infection with the "Catheter-Locking Device-Assisted" Technique: A Retrospective Study of 231 Patients.
World Neurosurg
September 2024
Department of Neurological Sciences, Neurosurgery, "La Sapienza" University of Rome, Rome, Italy.
Reply to: Femoral site for implantation of a port-a-catheter in a cancer patient.
Eur J Surg Oncol
February 2024
University of Genova, Genova, Italy. Electronic address:
Reply to: Opinion on exit-site care recommendations.
Perit Dial Int
January 2024
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Management of malignant pleural effusion in Italian clinical practice: a nationwide survey.
BMC Pulm Med
July 2023
Pulmonology Unit, ASST Spedali Civili, Brescia, Italy.
Background: Pleural disease (PD), particularly malignant pleural effusion (MPE), is a common cause of hospital admission and its prevalence is rising worldwide. Recent advances in diagnostic and therapeutic options, such as Indwelling Pleural Catheters (IPCs), have simplified PD treatment, allowing an effective outpatients management. Therefore, dedicated pleural services can improve PD care, guaranteeing specialized management and optimizing time and cost.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!